Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulated Induced Proximity Targeting Chimeras (RIPTACs): a Novel Heterobifunctional Small Molecule Therapeutic Strategy for Killing Cancer Cells Selectively
Kanak Raina, Chris D. Forbes, Rebecca Stronk, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Proximity-Based Modalities for Biology and Medicine
Xingui Liu, Alessio Ciulli
ACS Central Science (2023) Vol. 9, Iss. 7, pp. 1269-1284
Open Access | Times Cited: 73
Targeted protein degradation: from mechanisms to clinic
Jonathan M. Tsai, Radosław P. Nowak, Benjamin L. Ebert, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 9, pp. 740-757
Closed Access | Times Cited: 59
Targeted protein posttranslational modifications by chemically induced proximity for cancer therapy
Yunhua Peng, Jing Liu, Hiroyuki Inuzuka, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 4, pp. 104572-104572
Open Access | Times Cited: 26
Bifunctional Small Molecules That Induce Nuclear Localization and Targeted Transcriptional Regulation
William J. Gibson, Ananthan Sadagopan, Veronika M. Shoba, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 48, pp. 26028-26037
Open Access | Times Cited: 22
Drug Discovery Targeting Nuclear Receptor Binding SET Domain Protein 2 (NSD2)
Zonghui Ma, Andrew A. Bolinger, Haiying Chen, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 16, pp. 10991-11026
Open Access | Times Cited: 20
Molecular glue degraders: exciting opportunities for novel drug discovery
Thomas Lemaître, Marie Cornu, Florian Schwalen, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 4, pp. 433-449
Closed Access | Times Cited: 6
In vitro and in vivo enhancement effect of glabridin on the antibacterial activity of colistin, against multidrug resistant Escherichia coli strains
Jiaxing Yang, Laiying Zhang, Xinlian He, et al.
Phytomedicine (2024) Vol. 130, pp. 155732-155732
Closed Access | Times Cited: 5
p53 protein abundance is a therapeutic window across TP53 mutant cancers and is targetable with proximity inducing small molecules
Ananthan Sadagopan, Nicholas Garaffo, Heng-Jui Chang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Extrapolating Lessons from Targeted Protein Degradation to Other Proximity-Inducing Drugs
Georg E. Winter
ACS Chemical Biology (2024)
Open Access | Times Cited: 2
Facilitating the development of molecular glues: Opportunities from serendipity and rational design
Weiqing Jiang, Yunhan Jiang, Youfu Luo, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115950-115950
Closed Access | Times Cited: 7
A perspective on the changing landscape of HTS
Alice Lanne, Laura Usselmann, Poppy Llowarch, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 8, pp. 103670-103670
Closed Access | Times Cited: 6
RIPTACs: A groundbreaking approach to drug discovery
Zonghui Ma, Andrew A. Bolinger, Jia Zhou
Drug Discovery Today (2023) Vol. 28, Iss. 11, pp. 103774-103774
Open Access | Times Cited: 6
Bifunctional small molecules that induce nuclear localization and targeted transcriptional regulation
William J. Gibson, Ananthan Sadagopan, Veronika M. Shoba, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics
Yevgeniy V. Serebrenik, Deepak Mani, Timothé Maujean, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Proximity Biosensor Assay for PROTAC Ternary Complex Analysis
Irene Ponzo, Alice Soldà, Charlotte Crowe, et al.
(2024)
Open Access | Times Cited: 1
Application of covalent modality in proximity-induced drug pharmacology: Early development, current strategy, and feature directions
Linjie Li, Song Liu, Youfu Luo
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116394-116394
Closed Access | Times Cited: 1
Velcrin compounds activate the SLFN12 tRNase to induce tomoptosis
Heidi Greulich
Cell chemical biology (2024) Vol. 31, Iss. 6, pp. 1039-1043
Closed Access | Times Cited: 1
Pooled endogenous protein tagging and recruitment for systematic profiling of protein function
Yevgeniy V. Serebrenik, Deepak Mani, Timothé Maujean, et al.
Cell Genomics (2024), pp. 100651-100651
Open Access | Times Cited: 1
Exploitation of Proximity-Mediated Effects in Drug Discovery: An Update of Recent Research Highlights in Perturbing Pathogenic Proteins and Correlated Issues
Can Zhao, Henian Wang, Wenhu Zhan, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10122-10149
Closed Access | Times Cited: 3
The rise of targeting chimeras (TACs): next-generation medicines that preempt cellular events
Scott A. Hollingsworth, S.A. Johnson, Pouyan Khakbaz, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 7, pp. 1294-1314
Closed Access | Times Cited: 2
VIPER-TACs leverage viral E3 ligases for disease-specific targeted protein degradation
Kyle Mangano, Robert G. Guenette, Spencer Hill, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
To homeostasis and beyond! Recent advances in the medicinal chemistry of heterobifunctional derivatives
Diana Castagna, Benoit Gourdet, Roland Hjerpe, et al.
Progress in medicinal chemistry (2024), pp. 61-160
Closed Access
Recent breakthroughs in innovative elements, multidimensional enhancements, derived technologies, and novel applications of PROTACs
Si-Han Zhang, Na Zeng, Jin‐Zhou Xu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117584-117584
Open Access
Anticancer Ribosomally Synthesized and Post-Translationally Modified Peptides from Plants: Structures, Therapeutic Potential, and Future Directions
Hye Jin Hwang, Youngsang Nam, Chanhee Jang, et al.
Current Issues in Molecular Biology (2024) Vol. 47, Iss. 1, pp. 6-6
Open Access
Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics
Ophir Shalem, Yevgeniy V. Serebrenik, Deepak Mani, et al.
Research Square (Research Square) (2023)
Open Access
Page 1 - Next Page

Scroll to top